Chinese citizen journalist Zhang Zhan has been released from prison after serving four years for her coverage of Beijing's Covid-19 response, according to a video released by media watchdog Reporters Without Borders.

However, rights groups said Zhang was still under surveillance and that her freedom was extremely limited.&nbsp;

Zhang, a former lawyer, travelled to the central city of Wuhan in February 2020 to report on the chaos at the pandemic's epicentre, questioning the authorities' handling of the outbreak in her smartphone videos.

She was detained in May 2020 and sentenced seven months later to four years in jail for "picking quarrels and provoking trouble" -- a charge routinely used to suppress dissent.

Zhang was due to be released on May 13 but a lack of information about her whereabouts had sparked concern among rights groups and activists that she could still be detained.

A short video featuring a pyjama-clad Zhang shared by Reporters Without Borders (RSF) on Wednesday appeared to show she had been released as scheduled.

"Police released me from prison at five in the morning on May 13 and sent me to my older brother's home in Shanghai," Zhang said in the video, in a soft, halting voice.

"Thank you everyone for your help and concern, I wish you all the best... there is not much more that I can say," Zhang said.

It was unclear who filmed the video, with RSF saying it was released "via an intermediary".

While Zhang appears to have been released, "her contact with the outside world and daily life are all under surveillance", Jane Wang, a UK-based activist involved in the campaign to release and locate Zhang, wrote on social media platform X.

"She only has limited freedom," Wang said.

Activists as well as the United Nations' rights office have expressed concern about 40-year-old Zhang's health after she conducted several hunger strikes in prison to protest against her conviction.

"RSF remains concerned by her situation and emphasises that partial freedom is not freedom at all," the media watchdog wrote in a statement on Wednesday.

"Diplomatic intervention remains crucial to ensure her full and unconditional release without delay," RSF said.

Chinese citizen journalist Zhang Zhan has been released from prison after serving four years for her coverage of Beijing's Covid-19 response, according to a video released by media watchdog Reporters Without Borders.

Chinese citizen journalist Zhang Zhan has been released from prison after serving four years for her coverage of Beijing's Covid-19 response, according to a video released by media watchdog Reporters Without Borders. However, rights groups said Zhang was still under surveillance and that her freedom was extremely limited. Zhang, a former lawyer, travelled to the central city of Wuhan in February 2020 to report on the chaos at the pandemic's epicentre, questioning the authorities' handling of the outbreak in her smartphone videos. She was detained in May 2020 and sentenced seven months later to four years in jail for "picking quarrels and provoking trouble" -- a charge routinely used to suppress dissent. Zhang was due to be released on May 13 but a lack of information about her whereabouts had sparked concern among rights groups and activists that she could still be detained. A short video featuring a pyjama-clad Zhang shared by Reporters Without Borders (RSF) on Wednesday appeared to show she had been released as scheduled. "Police released me from prison at five in the morning on May 13 and sent me to my older brother's home in Shanghai," Zhang said in the video, in a soft, halting voice. "Thank you everyone for your help and concern, I wish you all the best... there is not much more that I can say," Zhang said. It was unclear who filmed the video, with RSF saying it was released "via an intermediary". While Zhang appears to have been released, "her contact with the outside world and daily life are all under surveillance", Jane Wang, a UK-based activist involved in the campaign to release and locate Zhang, wrote on social media platform X. "She only has limited freedom," Wang said. Activists as well as the United Nations' rights office have expressed concern about 40-year-old Zhang's health after she conducted several hunger strikes in prison to protest against her conviction. "RSF remains concerned by her situation and emphasises that partial freedom is not freedom at all," the media watchdog wrote in a statement on Wednesday. "Diplomatic intervention remains crucial to ensure her full and unconditional release without delay," RSF said.

China releases journalist jailed for Covid-19 coverage

While a study conducted by researchers at Banaras Hindu University (BHU) found that nearly one-third of those who received Bharat Biotech's Covid-19 vaccine Covaxin reported Adverse Events of Special Interest (AESI) after a one-year follow-up, the Hyderabad-based company cited research flaws. Watch to know more.

India: BHU study raises questions over Covaxin jab, says '1 in 3 reported adverse effects'

Were COVID-19 vaccines dangerous for your health? AstraZeneca, the maker of Covishield, has admitted that its vaccines can cause rare side effects. What does this mean for the billions who took COVID-19 vaccines? Do the benefits of these vaccines still outweigh the risk?

Gravitas | Were Covid Vaccines dangerous for your health?

A new family of variants of COVID-19 are doing rounds in the US- the ‘FLiRT’ variants. These variants are also from the deadly lineage of the Omicron variant but are derivatives of the JN.1, the variant that caused a surge in cases at the start of the year.&nbsp;

The letters in FLiRT variants are based on the technical names of their mutations, one which includes the letters F and L, and another one includes the letters R and T. Within this group of variants, one particular variant is of rising concern: KP.2.

As per the data gathered from the US Centres for Disease Control and Prevention (CDC), KP.2 has accounted for about 25 per cent of new sequenced cases during the two weeks ending April 27. However, other FLiRT variants, like KP.1.1, have not become as widespread in the US yet.&nbsp;

Also Read |&nbsp;<a href="https://www.wionews.com/world/pro-palestine-and-pro-israel-protestors-clash-at-ucla-campus-police-asked-to-step-in-717021">Pro-Palestine and Pro-Israel protestors clash at UCLA campus, police asked to step in</a>

But is this family of variants of concern?

<h2>Concerns around FLiRT variants</h2>

As per reports, researchers are still studying and gathering more information on FLiRT variants. Talking to Time, Dr Eric Topol, Executive Vice President at Scripps Research, said that the KP.2 variant from the family of variants is on the rise in the US, but it will be too soon to tell whether it will cause a major surge in cases in coming months.

Also Read |&nbsp;<a href="https://www.wionews.com/world/blinken-urges-hamas-to-agree-gaza-truce-as-he-meets-israel-leaders-717009">Blinken urges Hamas to accept Gaza truce as he meets Israel leaders</a>

For now, the amount of Covid-19 viruses in US wastewater remains “minimal,” according to the CDC. Hospitalisations and deaths have also continued to decline steadily since their recent peaks in January. At the global level, case counts rose from early to mid-April, but remain far lower than they were a few months ago.

Watch |&nbsp;Covid-19 makes global comeback; new Omicron sub-variant JN.1 causes global concern | WION

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/covid-19-makes-global-comeback-new-omicron-sub-variant-jn1-causes-global-concern-wion-671372/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

KP.2 and its relatives are likely to cause an uptick in cases in the States, but won’t cause a big wave, says Topol. “It might be a ‘wavelet.’” That’s because people who were recently infected by the JN.1 variant seem to have some protection against re-infection, Topol believes. Also, the virus hasn’t mutated enough to become wildly different from the previous strains.

A recent study from researchers in Japan, which was posted online before being peer-reviewed, also found that KP.2 is less infectious than JN.1.

Do vaccines work on FLiRT variants?

Vaccines are still a good prevention and protection option against any COVID-19-related hospitalisation and death. However, two preliminary studies, from Japan and China, show the FLiRT variants may be better at dodging immune protection from vaccines than JN.1 was.

And this is not a good sign, as many people, who got the recent booster shots, got it last fall. This means their protection has begun to diminish, Topol says.

Also Read |&nbsp;<a href="https://www.wionews.com/world/52-year-old-climber-dies-in-1000-foot-fall-from-alaska-mountain-716993">52-year-old climber dies in 1,000-foot fall from Alaska mountain</a>

It is still advisable to rely on vaccines. In an April 26 statement, the World Health Organization recommended basing future vaccine formulations on the JN.1 lineage, since it seems the virus will continue to evolve from that variant. The most recent booster was based on an older strain, XBB.1.5.

The virus is bound to evolve, but public health advice remains the same - vaccinate yourself, test before big gatherings, stay home when you’re ill and consider wearing masks in public places.

(With inputs from agencies)

A new family of variants of COVID-19 are doing rounds in the US- the ‘FLiRT’ variants. These variants are also from the deadly lineage of the Omicron variant but are derivatives of the JN.

A new family of variants of COVID-19 are doing rounds in the US- the ‘FLiRT’ variants. These variants are also from the deadly lineage of the Omicron variant but are derivatives of the JN.1, the variant that caused a surge in cases at the start of the year. The letters in FLiRT variants are based on the technical names of their mutations, one which includes the letters F and L, and another one includes the letters R and T. Within this group of variants, one particular variant is of rising concern: KP.2. As per the data gathered from the US Centres for Disease Control and Prevention (CDC), KP.2 has accounted for about 25 per cent of new sequenced cases during the two weeks ending April 27. However, other FLiRT variants, like KP.1.1, have not become as widespread in the US yet. Also Read | Pro-Palestine and Pro-Israel protestors clash at UCLA campus, police asked to step in But is this family of variants of concern? Concerns around FLiRT variants As per reports, researchers are still studying and gathering more information on FLiRT variants. Talking to Time, Dr Eric Topol, Executive Vice President at Scripps Research, said that the KP.2 variant from the family of variants is on the rise in the US, but it will be too soon to tell whether it will cause a major surge in cases in coming months. Also Read | Blinken urges Hamas to accept Gaza truce as he meets Israel leaders For now, the amount of Covid-19 viruses in US wastewater remains “minimal,” according to the CDC. Hospitalisations and deaths have also continued to decline steadily since their recent peaks in January. At the global level, case counts rose from early to mid-April, but remain far lower than they were a few months ago. Watch | Covid-19 makes global comeback; new Omicron sub-variant JN.1 causes global concern | WION × KP.2 and its relatives are likely to cause an uptick in cases in the States, but won’t cause a big wave, says Topol. “It might be a ‘wavelet.’” That’s because people who were recently infected by the JN.1 variant seem to have some protection against re-infection, Topol believes. Also, the virus hasn’t mutated enough to become wildly different from the previous strains. A recent study from researchers in Japan, which was posted online before being peer-reviewed, also found that KP.2 is less infectious than JN.1. Do vaccines work on FLiRT variants? Vaccines are still a good prevention and protection option against any COVID-19-related hospitalisation and death. However, two preliminary studies, from Japan and China, show the FLiRT variants may be better at dodging immune protection from vaccines than JN.1 was. And this is not a good sign, as many people, who got the recent booster shots, got it last fall. This means their protection has begun to diminish, Topol says. Also Read | 52-year-old climber dies in 1,000-foot fall from Alaska mountain It is still advisable to rely on vaccines. In an April 26 statement, the World Health Organization recommended basing future vaccine formulations on the JN.1 lineage, since it seems the virus will continue to evolve from that variant. The most recent booster was based on an older strain, XBB.1.5. The virus is bound to evolve, but public health advice remains the same - vaccinate yourself, test before big gatherings, stay home when you’re ill and consider wearing masks in public places. (With inputs from agencies)

New family of Covid-19 variants nicknamed ‘FLiRT’ are on the rise in US | All you need to know

The Chinese scientist who first published a sequence of the COVID-19 virus in January 2020 without state approval&nbsp;was reportedly forced&nbsp;out of his facility over the weekend. Zhang Yongzhen&nbsp;on&nbsp;Monday (Apr 29)&nbsp;wrote on Chinese social media that&nbsp;he and his team&nbsp;were asked&nbsp;to evict from the lab, the latest sign of increased scrutiny against scientists working on coronavirus in the communist country.

According to a report by news agency AP, when Zhang tried to enter his lab over the weekend, he was barred by guards who said the lab has been closed for “safety reasons.”

The scientist staged a protest outside the lab, with online photos showing him sitting in drizzling rain.&nbsp;

“I won’t leave, I won’t quit, I am pursuing science and the truth!,” he wrote in a post on the Chinese social media platform Weibo.

The news of his protest quickly spread on social media, prompting the Shanghai Public Health Clinical Center to issue a statement.

The centre claimed Zhang’s lab was&nbsp;being renovated&nbsp;and&nbsp;his team was provided&nbsp;with an alternative facility&nbsp;meanwhile.

However, Zhang rubbished the claim and said&nbsp;no alternative facility had been offered.&nbsp;

<h2>How&nbsp;Zhang&nbsp;ran afoul of the Chinese govt?</h2>

Zhang became a trouble for China’s Xi Jinping administration when, back in 2020, he and his team decoded the COVID-19 virus and warned the Chinese authorities of its potential to spread quickly among the masses.

The&nbsp;very&nbsp;next day, his lab faced action by the government&nbsp;and&nbsp;Zhang came under heavy government pressure.

In the meantime, foreign scientists started citing Zhang’s work while&nbsp;issuing calls to the Chinese government&nbsp;to take preventive measures.

Also read:&nbsp;<a data-ved="2ahUKEwjn0ZmGpOqFAxV7z6ACHdD6DioQxfQBKAB6BAgOEAE" href="https://www.wionews.com/world/scientist-who-developed-chinas-first-vaccine-now-facing-discipline-charges-expelled-from-parliament-716300" jsname="YKoRaf" ping="/url?sa=t&amp;source=web&amp;rct=j&amp;opi=89978449&amp;url=https://www.wionews.com/world/scientist-who-developed-chinas-first-vaccine-now-facing-discipline-charges-expelled-from-parliament-716300&amp;ved=2ahUKEwjn0ZmGpOqFAxV7z6ACHdD6DioQxfQBKAB6BAgOEAE">Scientist who developed China's first vaccine now facing disciplinary charges, expelled from parliament</a>

On January 11, 2020, Zhang made the virus sequence&nbsp;public,&nbsp;without waiting for the government’s nod.

Sequencing a virus is&nbsp;key&nbsp;to&nbsp;the development of&nbsp;test kits, disease control measures and vaccinations, reported AP.

<h2>Series of actions against Zhang</h2>

Zhang’s actions have brought him enough trouble over the past years.

Also read:&nbsp;<a data-ved="2ahUKEwjTo8mApOqFAxUW2TgGHS9TDi0QxfQBKAB6BAgQEAE" href="https://www.wionews.com/business-economy/chinese-firms-navigate-payment-hurdles-amid-russia-trade-troubles-716162" jsname="YKoRaf" ping="/url?sa=t&amp;source=web&amp;rct=j&amp;opi=89978449&amp;url=https://www.wionews.com/business-economy/chinese-firms-navigate-payment-hurdles-amid-russia-trade-troubles-716162&amp;ved=2ahUKEwjTo8mApOqFAxUW2TgGHS9TDi0QxfQBKAB6BAgQEAE">Chinese firms navigate payment hurdles amid Russia trade troubles</a>

Not only&nbsp;Zhang&nbsp;was&nbsp;expelled&nbsp;from a post at the Chinese Center for Disease Control and Prevention&nbsp;but was also stopped&nbsp;from collaborating with some of his former partners, which severely affected his research.

(With inputs from agencies)

The Chinese scientist who first published a sequence of the COVID-19 virus in January 2020 without state approval was reportedly forced out of his facility over the weekend.

The Chinese scientist who first published a sequence of the COVID-19 virus in January 2020 without state approval was reportedly forced out of his facility over the weekend. Zhang Yongzhen on Monday (Apr 29) wrote on Chinese social media that he and his team were asked to evict from the lab, the latest sign of increased scrutiny against scientists working on coronavirus in the communist country. According to a report by news agency AP, when Zhang tried to enter his lab over the weekend, he was barred by guards who said the lab has been closed for “safety reasons.” The scientist staged a protest outside the lab, with online photos showing him sitting in drizzling rain. “I won’t leave, I won’t quit, I am pursuing science and the truth!,” he wrote in a post on the Chinese social media platform Weibo. The news of his protest quickly spread on social media, prompting the Shanghai Public Health Clinical Center to issue a statement. The centre claimed Zhang’s lab was being renovated and his team was provided with an alternative facility meanwhile. However, Zhang rubbished the claim and said no alternative facility had been offered. How Zhang ran afoul of the Chinese govt? Zhang became a trouble for China’s Xi Jinping administration when, back in 2020, he and his team decoded the COVID-19 virus and warned the Chinese authorities of its potential to spread quickly among the masses. The very next day, his lab faced action by the government and Zhang came under heavy government pressure. In the meantime, foreign scientists started citing Zhang’s work while issuing calls to the Chinese government to take preventive measures. Also read: Scientist who developed China's first vaccine now facing disciplinary charges, expelled from parliament On January 11, 2020, Zhang made the virus sequence public, without waiting for the government’s nod. Sequencing a virus is key to the development of test kits, disease control measures and vaccinations, reported AP. Series of actions against Zhang Zhang’s actions have brought him enough trouble over the past years. Also read: Chinese firms navigate payment hurdles amid Russia trade troubles Not only Zhang was expelled from a post at the Chinese Center for Disease Control and Prevention but was also stopped from collaborating with some of his former partners, which severely affected his research. (With inputs from agencies)

Scientist who first decoded the Covid sequence thrown out of his lab by China

A Dutch man lost the battle for life after suffering from coronavirus (COVID-19) for a record 613 days during which&nbsp;the virus mutated multiple times turning into a unique new variant, Time reported, citing research from the University of Amsterdam.&nbsp;The 72-year-old unnamed patient's condition surprised the medical researchers, who said that it is the longest time anyone has been infected with the virus.&nbsp;

The report said that the patient succumbed to an underlying illness, after a weakened immune system due to the virus.&nbsp;

In February 2022, the patient was infected with the omicron variant of COVID-19, which was once labelled as a "variant of concern" by the World Health Organization (WHO).&nbsp;

Also read:&nbsp;<a href="https://www.wionews.com/science/one-in-three-people-suffer-from-silent-killer-cardiac-disease-study-713100">One in three people suffer from 'silent killer' condition: Study</a>&nbsp;

He had a blood disorder, and before catching omicron, he failed to have a strong immune response to multiple Covid shots.&nbsp;

Researchers did a detailed analysis of specimens collected from more than two dozen nose and throat swabs. They discovered that the virus developed resistance to sotrovimab, which is a Covid antibody treatment within a few weeks.&nbsp;

Also read:&nbsp;<a href="https://www.wionews.com/science/scientists-make-deadly-discovery-of-vampire-bacteria-which-feasts-on-human-blood-712171">'Vampire' bacteria: Some common pathogens are now feasting on human blood</a>&nbsp;

Watch:&nbsp;Hug your way to better health

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/hug-your-way-to-better-health-712470/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

The scientists at the University of Amsterdam's Centre for Experimental and Molecular Medicine said that Covid in his body later acquired over 50 mutations. Some specimens also suggested that the virus developed an enhanced ability to evade immune defences in the man's body.&nbsp;

As quoted in the report, the authors said, "This case underscores the risk of persistent SARS-CoV-2 infections in immunocompromised individuals. We emphasize the importance of continuing genomic surveillance of SARS-CoV-2 evolution in immunocompromised individuals with persistent infections."&nbsp;

Meanwhile, a latest study led by the Centre for Epidemiological Studies on STIs and AIDS of Catalonia (CEEISCAT) has revealed that people living with HIV who have contracted Covid face a significant increase in the risk of cardiovascular diseases in the year following infection.&nbsp;

A Dutch man lost the battle for life after suffering from coronavirus (COVID-19) for a record 613 days during which the virus mutated multiple times turning into a unique new variant, Time reported, citing research from the University of Amsterdam.

A Dutch man lost the battle for life after suffering from coronavirus (COVID-19) for a record 613 days during which the virus mutated multiple times turning into a unique new variant, Time reported, citing research from the University of Amsterdam. The 72-year-old unnamed patient's condition surprised the medical researchers, who said that it is the longest time anyone has been infected with the virus. The report said that the patient succumbed to an underlying illness, after a weakened immune system due to the virus. In February 2022, the patient was infected with the omicron variant of COVID-19, which was once labelled as a "variant of concern" by the World Health Organization (WHO). Also read: One in three people suffer from 'silent killer' condition: Study He had a blood disorder, and before catching omicron, he failed to have a strong immune response to multiple Covid shots. Researchers did a detailed analysis of specimens collected from more than two dozen nose and throat swabs. They discovered that the virus developed resistance to sotrovimab, which is a Covid antibody treatment within a few weeks. Also read: 'Vampire' bacteria: Some common pathogens are now feasting on human blood Watch: Hug your way to better health × The scientists at the University of Amsterdam's Centre for Experimental and Molecular Medicine said that Covid in his body later acquired over 50 mutations. Some specimens also suggested that the virus developed an enhanced ability to evade immune defences in the man's body. As quoted in the report, the authors said, "This case underscores the risk of persistent SARS-CoV-2 infections in immunocompromised individuals. We emphasize the importance of continuing genomic surveillance of SARS-CoV-2 evolution in immunocompromised individuals with persistent infections." Meanwhile, a latest study led by the Centre for Epidemiological Studies on STIs and AIDS of Catalonia (CEEISCAT) has revealed that people living with HIV who have contracted Covid face a significant increase in the risk of cardiovascular diseases in the year following infection.

72-year-old dies after living with Covid for record 613 days, virus mutated over 50 times

State and federal prisons emerged as hotbeds for the COVID-19 virus in the wake of its outbreak in the US as there was a heightened risk faced by incarcerated individuals. Research&nbsp;from the University of California, Irvine, and Brigham and Women’s Hospital highlighted the staggering toll and revealed that at the pandemic's zenith in 2020, those inside prisons were nearly three-and-a-half times more likely to have died from the virus compared to the general population outside.&nbsp;

The study, drawn&nbsp;from state prison systems and the Federal Bureau of Prisons, documented over 6,000 deaths among incarcerated individuals in the first year of the pandemic. The analysis illustrated a stark increase of at least 50 percent in the overall prison mortality rate, with potentially over 75 per cent spike.&nbsp;

<a href="https://www.wionews.com/world/watch-biden-mixes-up-rafah-with-israeli-city-haifa-he-says-dont-move-712592">WATCH | Biden mixes up Rafah with Israeli city Haifa, says 'don’t move...'</a>

The impact was particularly severe on older prisoners, with death rates among those aged 50 and above soaring. Lead author of the study, Naomi Sugie, pointed out this disparity and noted how older inmates faced greater risks.

The data revealed that there was a reduction in prison admissions even when there was no increase in releases. This reduction inadvertently shielded younger individuals from COVID-19 exposure, as incarcerated populations tend to be older.

Also Read |&nbsp;<a href="https://www.wionews.com/world/iran-escalates-hijab-crackdown-victims-speak-out-against-morality-police-abuse-712574">Iran escalates hijab crackdown, victims speak out against morality police abuse</a>

Governors, vested with the power to release prisoners, hesitated to take decisive action, with concerns over potential backlash over decision-making. Only a handful of parole boards saw notable increases in releases, with Iowa standing out for more releases.

Mitigation efforts varied widely across states, with some implementing aggressive testing and lockdown measures, while others lagged behind and resorted to calling in external support as deaths surged. Illinois, for instance, struggled to swiftly implement protective measures amid escalating fatalities.

Watch |&nbsp;<a href="https://www.wionews.com/videos/nasa-chief-raises-alarm-over-increasing-chinese-military-presence-in-space-712618">NASA chief raises alarm over increasing Chinese military presence in space</a>

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/nasa-chief-raises-alarm-over-increasing-chinese-military-presence-in-space-712618/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

Speaking over the Bureau of Justice Statistics that has yet to publish the&nbsp;mortality data,&nbsp;Sugie, the study’s author said, “this is really both to have an accounting of what happened... but also, really importantly, to learn from what happened, so we don’t do this again in the future when we have another pandemic, another crisis.”

(With inputs from agencies)

State and federal prisons emerged as hotbeds for the COVID-19 virus in the wake of its outbreak in the US as there was a heightened risk faced by incarcerated individuals.

State and federal prisons emerged as hotbeds for the COVID-19 virus in the wake of its outbreak in the US as there was a heightened risk faced by incarcerated individuals. Research from the University of California, Irvine, and Brigham and Women’s Hospital highlighted the staggering toll and revealed that at the pandemic's zenith in 2020, those inside prisons were nearly three-and-a-half times more likely to have died from the virus compared to the general population outside. The study, drawn from state prison systems and the Federal Bureau of Prisons, documented over 6,000 deaths among incarcerated individuals in the first year of the pandemic. The analysis illustrated a stark increase of at least 50 percent in the overall prison mortality rate, with potentially over 75 per cent spike. WATCH | Biden mixes up Rafah with Israeli city Haifa, says 'don’t move...' The impact was particularly severe on older prisoners, with death rates among those aged 50 and above soaring. Lead author of the study, Naomi Sugie, pointed out this disparity and noted how older inmates faced greater risks. The data revealed that there was a reduction in prison admissions even when there was no increase in releases. This reduction inadvertently shielded younger individuals from COVID-19 exposure, as incarcerated populations tend to be older. Also Read | Iran escalates hijab crackdown, victims speak out against morality police abuse Governors, vested with the power to release prisoners, hesitated to take decisive action, with concerns over potential backlash over decision-making. Only a handful of parole boards saw notable increases in releases, with Iowa standing out for more releases. Mitigation efforts varied widely across states, with some implementing aggressive testing and lockdown measures, while others lagged behind and resorted to calling in external support as deaths surged. Illinois, for instance, struggled to swiftly implement protective measures amid escalating fatalities. Watch | NASA chief raises alarm over increasing Chinese military presence in space × Speaking over the Bureau of Justice Statistics that has yet to publish the mortality data, Sugie, the study’s author said, “this is really both to have an accounting of what happened... but also, really importantly, to learn from what happened, so we don’t do this again in the future when we have another pandemic, another crisis.” (With inputs from agencies)

US prisons were Covid hotbeds, inmates died nearly 3.5 times more than those outside

The coronavirus (COVID-19) pandemic has subsided, but its impact can still be seen as long Covid. Hence, regular monitoring of cases and symptoms, in the form of testing, is necessary.&nbsp;

As we all know samples for Covid diagnostic tests are typically collected using an anterior nares (nasal) swab sample. Some diagnostic tests involve other samples such as mid-turbinate, nasopharyngeal, oropharyngeal, or saliva.&nbsp;

Meanwhile, in the latest development, Johns Hopkins University has highlighted research that shows artificial intelligence (AI) can spot Covid in lung ultrasound images.&nbsp;

Also read:&nbsp;<a href="https://www.wionews.com/entertainment/lifestyle/news-dont-let-menopause-pause-you-embrace-it-with-confidence-and-dismantle-stigmas-699612">Don't let menopause pause you, embrace it with confidence and dismantle stigmas</a>&nbsp;

Researchers published a study on March 11 in <a href="https://www.nature.com/articles/s43856-024-00463-5">Communications Medicine</a> that aims to explain the creation of an AI system that analyses lung ultrasound pictures.&nbsp;

The scans detect patterns known as B-lines, which show as bright, vertical anomalies and suggest inflammation in patients with pulmonary problems.&nbsp;

In a news release, the university said, "The findings culminate an effort that started early in the pandemic when clinicians needed tools to rapidly assess legions of patients in overwhelmed emergency rooms."&nbsp;

Also read:&nbsp;<a href="https://www.wionews.com/health-and-wellness/rising-cases-of-silent-heart-attacks-linked-to-long-covid-wion-decodes-687662">Rising cases of silent heart attacks linked to long Covid? WION decodes</a>&nbsp;

The study further noted that the AI was trained by mixing computer-generated images with actual ultrasounds of patients, including some of those who sought care at Johns Hopkins.&nbsp;

As quoted, first author Lingyi Zhao, PhD, who developed the software during postdoctoral fellowship work, said, "Early in the pandemic, we didn't have enough ultrasound images of COVID-19 patients to develop and test our algorithms, and as a result, our deep neural networks never reached peak performance."&nbsp;

Further, the researchers taught the AI to learn from a combination of real and simulated data in order to identify abnormalities in ultrasound scans that suggest a person has COVID-19.&nbsp;

Zhao explained that the tool is a deep neural network, a sort of artificial intelligence designed to act similarly to the interconnected neurons that allow the brain to recognise patterns, process speech, and perform other complicated tasks.&nbsp;

(With inputs from agencies)&nbsp;

The coronavirus (COVID-19) pandemic has subsided, but its impact can still be seen as long Covid. Hence, regular monitoring of cases and symptoms, in the form of testing, is necessary.

The coronavirus (COVID-19) pandemic has subsided, but its impact can still be seen as long Covid. Hence, regular monitoring of cases and symptoms, in the form of testing, is necessary. As we all know samples for Covid diagnostic tests are typically collected using an anterior nares (nasal) swab sample. Some diagnostic tests involve other samples such as mid-turbinate, nasopharyngeal, oropharyngeal, or saliva. Meanwhile, in the latest development, Johns Hopkins University has highlighted research that shows artificial intelligence (AI) can spot Covid in lung ultrasound images. Also read: Don't let menopause pause you, embrace it with confidence and dismantle stigmas Researchers published a study on March 11 in Communications Medicine that aims to explain the creation of an AI system that analyses lung ultrasound pictures. The scans detect patterns known as B-lines, which show as bright, vertical anomalies and suggest inflammation in patients with pulmonary problems. In a news release, the university said, "The findings culminate an effort that started early in the pandemic when clinicians needed tools to rapidly assess legions of patients in overwhelmed emergency rooms." Also read: Rising cases of silent heart attacks linked to long Covid? WION decodes The study further noted that the AI was trained by mixing computer-generated images with actual ultrasounds of patients, including some of those who sought care at Johns Hopkins. As quoted, first author Lingyi Zhao, PhD, who developed the software during postdoctoral fellowship work, said, "Early in the pandemic, we didn't have enough ultrasound images of COVID-19 patients to develop and test our algorithms, and as a result, our deep neural networks never reached peak performance." Further, the researchers taught the AI to learn from a combination of real and simulated data in order to identify abnormalities in ultrasound scans that suggest a person has COVID-19. Zhao explained that the tool is a deep neural network, a sort of artificial intelligence designed to act similarly to the interconnected neurons that allow the brain to recognise patterns, process speech, and perform other complicated tasks. (With inputs from agencies)

Artificial intelligence tool detects COVID-19 in lung ultrasound images: Study

Scientists have claimed that leakiness in the brain could be blamed for memory and concentration problems people generally experience during long Covid. These symptoms occur when the blood-brain barrier gets damaged and becomes ‘leaky.’ The blood-brain barrier controls what enters and exits the brain.

“It’s all about regulating a balance of material in blood compared to brain,” said Prof Matthew Campbell, co-author of the research at Trinity College Dublin.

“If that is off balance then it can drive changes in neural function and if this happens in brain regions that allow for memory consolidation/storage then it can wreak havoc,” he adds.

Campbell and his colleagues published the findings in the journal Nature Neuroscience after analysing serum and plasma samples from 76 patients who were hospitalised with Covid in March or April 2020 as well as 25 people before the pandemic.

<h2>Protein S100β</h2>

The team made several discoveries, notably finding increased levels of the protein S100β in samples from 14 Covid patients who reported brain fog compared to those without this symptom.

S100β, typically confined to brain cells, appeared in the blood of these patients, indicating a problem with the blood-brain barrier.

Subsequently, the researchers enlisted 10 Covid-recovered individuals and 22 long Covid patients, including 11 with brain fog, none of whom had received a Covid vaccine or been hospitalised.

Also read:&nbsp;<a data-ved="2ahUKEwj_392AqPiEAxVVZmwGHZ8rAwwQxfQBKAB6BAgOEAE" href="https://www.wionews.com/health-and-wellness/measurable-impact-of-brain-fog-linked-to-long-covid-study-695157" jsname="YKoRaf" ping="/url?sa=t&amp;source=web&amp;rct=j&amp;opi=89978449&amp;url=https://www.wionews.com/health-and-wellness/measurable-impact-of-brain-fog-linked-to-long-covid-study-695157&amp;ved=2ahUKEwj_392AqPiEAxVVZmwGHZ8rAwwQxfQBKAB6BAgOEAE">Measurable impact of `brain fog` linked to long Covid: Study</a>

Following MRI scans with intravenous dye, it was confirmed that long Covid patients experiencing brain fog had their blood-brain barrier leaky, unlike those without this symptom.

Campbell speculated that individuals with a more intact blood-brain barrier might be less susceptible to brain fog during long Covid.

<h2>Results not surprising</h2>

Campbell said the results were not surprising as disruptions to proteins involved in clotting could go hand in hand with disruption to cells that lined blood vessels. “The whole concept that a lot of these neurological conditions, including brain fog, could be treated by simply regulating the integrity of the blood-brain barrier is really exciting,” he said.

In an earlier study, scientists had speculated that blood clots in the brain may be causing brain fog in people with long Covid. Prof Paul Harrison from the University of Oxford, an author of earlier work, acknowledged that the new study was important.

“It shows that abnormalities in the lining of blood vessels in the brain occur in people with post-Covid brain fog, and adds to the evidence that abnormal blood clotting also contributes,” he was quoted as saying by the Guardian.

(With inputs from agencies)

Scientists have claimed that leakiness in the brain could be blamed for memory and concentration problems people generally experience during long Covid. These symptoms occur when the blood-brain barrier gets damaged and becomes ‘leaky.

Scientists have claimed that leakiness in the brain could be blamed for memory and concentration problems people generally experience during long Covid. These symptoms occur when the blood-brain barrier gets damaged and becomes ‘leaky.’ The blood-brain barrier controls what enters and exits the brain. “It’s all about regulating a balance of material in blood compared to brain,” said Prof Matthew Campbell, co-author of the research at Trinity College Dublin. “If that is off balance then it can drive changes in neural function and if this happens in brain regions that allow for memory consolidation/storage then it can wreak havoc,” he adds. Campbell and his colleagues published the findings in the journal Nature Neuroscience after analysing serum and plasma samples from 76 patients who were hospitalised with Covid in March or April 2020 as well as 25 people before the pandemic. Protein S100β The team made several discoveries, notably finding increased levels of the protein S100β in samples from 14 Covid patients who reported brain fog compared to those without this symptom. S100β, typically confined to brain cells, appeared in the blood of these patients, indicating a problem with the blood-brain barrier. Subsequently, the researchers enlisted 10 Covid-recovered individuals and 22 long Covid patients, including 11 with brain fog, none of whom had received a Covid vaccine or been hospitalised. Also read: Measurable impact of `brain fog` linked to long Covid: Study Following MRI scans with intravenous dye, it was confirmed that long Covid patients experiencing brain fog had their blood-brain barrier leaky, unlike those without this symptom. Campbell speculated that individuals with a more intact blood-brain barrier might be less susceptible to brain fog during long Covid. Results not surprising Campbell said the results were not surprising as disruptions to proteins involved in clotting could go hand in hand with disruption to cells that lined blood vessels. “The whole concept that a lot of these neurological conditions, including brain fog, could be treated by simply regulating the integrity of the blood-brain barrier is really exciting,” he said. In an earlier study, scientists had speculated that blood clots in the brain may be causing brain fog in people with long Covid. Prof Paul Harrison from the University of Oxford, an author of earlier work, acknowledged that the new study was important. “It shows that abnormalities in the lining of blood vessels in the brain occur in people with post-Covid brain fog, and adds to the evidence that abnormal blood clotting also contributes,” he was quoted as saying by the Guardian. (With inputs from agencies)

Leakiness in brain may be causing ‘brain fog’ experienced during long Covid: Study

On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a global pandemic. Since then, millions have died, and even more millions infected. This was the biggest health crisis in a century and spared no one. So what went wrong in the handling of the COVID-19 pandemic? WION Decodes the story for you.

COVID pandemic anniversary: How a virus led to collapse of global health system | WION Decodes

In a bizarre case from Germany, a 62-year-old man was vaccinated more than 200 times against COVID-19 and surprisingly suffered no side effects from them. The man was given vaccine shots privately within the duration of 29 months, which is against the medical advice of doctors.

This unique medical case is documented in The Lancet Infectious Diseases journal.&nbsp;

The case was taken up further by the researchers at the University of Erlangen-Nuremberg when they came across it through newspaper articles. The team of researchers at the university decided to study the curious case and called the man to undergo various tests in Erlangen.

Also Read |&nbsp;<a href="https://www.wionews.com/world/israel-wont-impose-new-limits-on-number-of-worshippers-at-al-aqsa-mosque-during-ramadan-697105">Israel won't impose new limits on number of worshippers at Al-Aqsa Mosque during Ramadan</a>

The tests were led by Dr Kilian Schober, from the university’s microbiology department. For the tests, the German provided a fresh sample of his blood and saliva to the team. The researchers also tested some frozen samples of his that had been stored in recent years.

<h2>Even after 200 jabs, no side effects were detected</h2>

The 62-year-old German man (whose name is not revealed yet), took a total of 217 vaccine shots as protection against the deadly COVID-19 infections. Even after hyper-vaccination, the man did not experience any side effects.

The team took the blood samples of the man after he received a further vaccination during the study at his own insistence.&nbsp;

Also Read |&nbsp;<a href="https://www.wionews.com/business-economy/abu-dhabis-state-oil-company-harnesses-ai-adds-500-million-in-net-value-in-2023-697095">Abu Dhabi’s state oil company harnesses AI, adds $500 million in net value in 2023</a>

Though COVID-19 vaccines cannot cause any infection, they&nbsp;teach the body how to fight the disease.&nbsp;Vaccines generally have messenger ribonucleic acid or mRNA inside them, which helps the body cells replicate the genetic code from the virus.&nbsp;

Watch |&nbsp;Gravitas: What Do We Truly Know About Covid Vaccines? The Unseen Consequences on Women's Health

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/gravitas-what-do-we-truly-know-about-covid-vaccines-the-unseen-consequences-on-womens-health-641072/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

The immune system then recognises the code and is able to fight off COVID-19, when encountered. But hyper-stimulating the immune system with repeated vaccinations might fatigue certain cells in the body, said Dr Schober. But no such sign or evidence of ill effect was found in the body of the 62-year-old.&nbsp;

Hyper-vaccination is not ideal &nbsp;

After the study, the researchers concluded that they do not “endorse hyper-vaccination as a strategy to enhance adaptive immunity".

The results of their tests on the 62-year-old were insufficient for making far-reaching conclusions, let alone recommendations for the general public.

Also Read |&nbsp;<a href="https://www.wionews.com/business-economy/starbucks-west-asia-franchisee-alshaya-to-cut-thousands-of-jobs-amid-boycott-fallout-697065">Starbucks West Asia franchisee AlShaya to cut thousands of jobs amid boycott fallout</a>

"Current research indicates that a three-dose vaccination, coupled with regular top-up vaccines for vulnerable groups, remains the favoured approach," they say on the university's website.

"There is no indication that more vaccines are required."

The COVID-19 vaccine can have side effects, and the most common one is a sore arm from the injection.

(With inputs from agencies)

In a bizarre case from Germany, a 62-year-old man was vaccinated more than 200 times against COVID-19 and surprisingly suffered no side effects from them. The man was given vaccine shots privately within the duration of 29 months, which is against the medical advice of doctors.

In a bizarre case from Germany, a 62-year-old man was vaccinated more than 200 times against COVID-19 and surprisingly suffered no side effects from them. The man was given vaccine shots privately within the duration of 29 months, which is against the medical advice of doctors. This unique medical case is documented in The Lancet Infectious Diseases journal. The case was taken up further by the researchers at the University of Erlangen-Nuremberg when they came across it through newspaper articles. The team of researchers at the university decided to study the curious case and called the man to undergo various tests in Erlangen. Also Read | Israel won't impose new limits on number of worshippers at Al-Aqsa Mosque during Ramadan The tests were led by Dr Kilian Schober, from the university’s microbiology department. For the tests, the German provided a fresh sample of his blood and saliva to the team. The researchers also tested some frozen samples of his that had been stored in recent years. Even after 200 jabs, no side effects were detected The 62-year-old German man (whose name is not revealed yet), took a total of 217 vaccine shots as protection against the deadly COVID-19 infections. Even after hyper-vaccination, the man did not experience any side effects. The team took the blood samples of the man after he received a further vaccination during the study at his own insistence. Also Read | Abu Dhabi’s state oil company harnesses AI, adds $500 million in net value in 2023 Though COVID-19 vaccines cannot cause any infection, they teach the body how to fight the disease. Vaccines generally have messenger ribonucleic acid or mRNA inside them, which helps the body cells replicate the genetic code from the virus. Watch | Gravitas: What Do We Truly Know About Covid Vaccines? The Unseen Consequences on Women's Health × The immune system then recognises the code and is able to fight off COVID-19, when encountered. But hyper-stimulating the immune system with repeated vaccinations might fatigue certain cells in the body, said Dr Schober. But no such sign or evidence of ill effect was found in the body of the 62-year-old. Hyper-vaccination is not ideal After the study, the researchers concluded that they do not “endorse hyper-vaccination as a strategy to enhance adaptive immunity". The results of their tests on the 62-year-old were insufficient for making far-reaching conclusions, let alone recommendations for the general public. Also Read | Starbucks West Asia franchisee AlShaya to cut thousands of jobs amid boycott fallout "Current research indicates that a three-dose vaccination, coupled with regular top-up vaccines for vulnerable groups, remains the favoured approach," they say on the university's website. "There is no indication that more vaccines are required." The COVID-19 vaccine can have side effects, and the most common one is a sore arm from the injection. (With inputs from agencies)

German man gets 217 Covid vaccinations in less than three years, scientists issue warning

Biological changes in babies born during the COVID-19 pandemic have astounded researchers. According to the study published in Allergy, Covid babies have an altered gut microbiome.

Biological changes in babies born during the COVID-19 pandemic have astounded researchers. According to the study published in Allergy, Covid babies have an altered gut microbiome. It means the system of good and bad bacteria in their gut that aids digestion and removes harmful bacteria is slightly distinct in children entering their toddler and early childhood years. The study by the research team from the University of College Cork in Ireland analysed faecal samples of 351 Irish babies born in the first three months of the COVID-19 pandemic between March and May 2020. They compared these samples to those from the babies born before the pandemic. The research team found that these gut bacteria alterations meant that these Covid babies have a lower-than-expected rate of allergic conditions than babies born before the pandemic. Only five per cent of the Covid babies developed a food allergy by the age of one, compared to the 22.8 per cent seen in the pre-Covid babies. According to the researchers, the mothers have passed healthy microbes to their babies while pregnant. These babies gained additional microbes from the environment after they were born. The study also revealed that the Covid babies required fewer antibiotics to treat illness. ALSO READ | Webb Telescope reveals how space finally shed its darkness to adorn brightness Liam O'Mahony, the joint senior author and professor of immunology at the University College Cork, called it a "fascinating outcome." Professor Jonathan Hourihane, the consultant paediatrician at Children's Health Ireland Temple Street and joint senior author, said, "This study offers a new perspective on the impact of social isolation in early life on the gut microbiome. Notably, the lower allergy rates among newborns during the lockdown could highlight the impact of lifestyle and environmental factors, such as frequent antibiotic use, on the rise of allergic diseases." Recently, parents were warned to look out for the latest symptoms of COVID-19 in babies. In the United States, scientists conducted research on the children who were diagnosed with the virus, reported Mail Online. They found that a "high proportion" of the children had increased levels of a biomarker linked with vascular trauma, a blood vessel injury. The study, published in the journal Blood Advances, analysed how coronavirus can alter children's cardiovascular health. The research team examined 50 paediatric patients hospitalised with the infection from April and July 2020. Dr David Teachey of the Children’s Hospital of Philadelphia said, "Although most children with COVID-19 do not have severe disease, our study shows that there may be other effects of SARS-CoV-2 that are worthy of investigation." (With inputs from agencies)

Babies born during COVID-19 pandemic show ‘fascinating’ biological alterations, says study

Covid-19 is not a thing of the past. A new study suggests that long Covid may lead to measurable cognitive decline. Molly Gambhir tells you more about how Covid hits your brain long after infection.

Gravitas | How Covid hits your brain long after infection

A study has found that COVID-19 affected the lungs of Indians more than the lungs of patients in Europe or China. What explains this discrimination? Also, how can you know if your lungs are safe?

Gravitas | Long Covid: Why Indians are more affected than the Chinese

The latest data released by The World Health Organization suggests the real COVID-19 death figures might be three times the reported numbers. Till now the official data has reported over 7 million fatalities from the beginning of the pandemic until the end of 2023 and now WHO states that the actual number of deaths from the disease may be closer to 21 million.

COVID-19 deaths controversy: Global death toll maybe triple the reported deaths

Pets having close contact with their owners, including sharing beds, snuggling and eating in the same area, might be more prone to catching human illnesses. According to a study published in Zoonoses: Infections Affecting Humans and Animals, pets can catch several diseases from their human owners, including swine flu, human norovirus, COVID-19 and tuberculosis to dengue, fungal infections and parasites.

Pets having close contact with their owners, including sharing beds, snuggling and eating in the same area, might be more prone to catching human illnesses. According to a study published in Zoonoses: Infections Affecting Humans and Animals, pets can catch several diseases from their human owners, including swine flu, human norovirus, COVID-19 and tuberculosis to dengue, fungal infections and parasites. While dogs and cats reported the most cases, researchers found a few in horses, ferrets and parrots. Zoonoses are diseases which pass between humans and other species. Over 60 per cent of human pathogens are zoonotic in origin. When humans pass diseases to animals, it is called reverse zoonosis. Benjamin Anderson, the study's author and an assistant professor at the University of Florida's College of Public Health and Health Professions, said, "We're starting to see examples of reverse zoonosis. Pets are more susceptible than, maybe, we previously thought." He added, "Typically, the viruses that I will have as a human are not going to fit into the receptors that a dog or cat has." ALSO READ | Mysterious radio signals might be coming from a black hole in the Milky Way However, some pathogens, like COVID-19 and flu, mutate to have a structure that allows them to penetrate through the cells of another species. This way, they can transfer between two species. Zoonosis and reverse zoonosis occur between mammals, as species more closely related are more prone to transferable diseases. But sometimes, the pathogen mutates enough to jump the gap and spreads between mammals, birds, or even reptiles. According to the study, reverse zoonosis provides another channel for diseases to spread. It has the potential to amplify an epidemic endangering humans. For instance, pigs infected by human flu and bird flu serve as a mixing pot for new viruses. "While pathogens certainly can move from animals to other animals and can be picked up from the environment, exposure to humans also plays an important role. It's this constant back-and-forth exchange that happens over time, increasing the probability of a mutation taking place that allows the pathogen to infect a new host," Anderson said. When animals get affected by human diseases, it is more complicated to track them as they don't often exhibit infections. The study's authors have urged people with pets to avoid close contact with the animals, especially in case of COVID-19 or flu. It's not always possible to keep your pets away for people who have strong bonds with their pets or those with a service animal. In such cases, people should ensure that the animal does not come in contact with body fluids like sneezes or snot. (With inputs from agencies)

Beware! You might be making your pets sick unknowingly, new study suggests

The World Health Organisation (WHO) on Wednesday (Jan 10) said that coronavirus (COVID-19) cases last month saw a rise during holiday gatherings globally fuelled by the most prominent variant.&nbsp;

Tedros Adhanom Ghebreyesus, the Director-General of WHO, said that nearly 10,000 deaths were reported in December.&nbsp;

Meanwhile, hospital admissions jumped 42 per cent during the month in nearly 50 countries. The cases were mostly reported in Europe and the Americas.&nbsp;

"Although 10,000 deaths a month is far less than the peak of the pandemic, this level of preventable deaths is not acceptable," the WHO chief told reporters from its headquarters in Geneva.&nbsp;

Also read:&nbsp;<a href="https://www.wionews.com/india-news/india-covid-kills-two-in-maharashtra-karnataka-as-cases-rise-due-to-jn1-sub-variant-678979">Covid kills two in Maharashtra, Karnataka as cases rise due to JN.1 sub-variant</a>&nbsp;

WHO chief said that it was "certain" that cases were on the rise in other places that haven't been reporting. He also urged the governments to track Covid cases and provide continued access to treatments and vaccines.&nbsp;

According to Tedros, the JN.1 variant was now the most prominent in the world. It is an omicron variant, so current vaccines should still provide some protection.&nbsp;

As quoted by The Associated Press, Maria Van Kerkhove, who is the technical lead at WHO for Covid, cited an increase in respiratory diseases across the globe due to the coronavirus but also flu, rhinovirus and pneumonia.&nbsp;

While talking about increases in Covid in the southern hemisphere — where it's now summer, she said: "We expect those trends to continue into January through the winter months in the northern hemisphere."&nbsp;

Also read:&nbsp;<a href="https://www.wionews.com/world/thailand-seeks-public-opinion-as-it-moves-to-ban-recreational-cannabis-use-after-historic-decriminalisation-678708">Thailand seeks public opinion as it moves to ban recreational cannabis use, after historic decriminalisation</a>

Van Kerkhove further said this year in particular, "we are seeing co-circulation of many different types of pathogens" as she mentioned cough, sniffling, fever and fatigue in the winter are nothing new.&nbsp;

Vaccination, wearing masks, and proper ventilation are some of the recommendations given by WHO officials.&nbsp;

Dr Michael Ryan, head of emergencies at WHO, said: "The vaccines may not stop you being infected, but the vaccines are certainly reducing significantly your chance of being hospitalized or dying."&nbsp;

Watch:&nbsp;At least 300 dead as Congo River basin submerged by generational floods&nbsp;

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/at-least-300-dead-as-congo-river-basin-submerged-by-generational-floods-678960/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<h2>Mask mandate in Spain&nbsp;</h2>

The report by WHO comes amid Spain imposing&nbsp;mask mandate in hospitals and other healthcare facilities from Wednesday to curb Covid cases, the health ministry said on Monday as the country faces a flu outbreak.&nbsp;

The decree was announced after a meeting between the health ministry and representatives of the country's regions, who control their own health systems.&nbsp;

Spanish Health Minister Monica Garcia after the meeting said,&nbsp;"Since the pandemic, we have learnt. We have thought hard about the issue of the mask to protect above all health centres and hospitals, to protect patients as much as (healthcare) professionals."&nbsp;

(With inputs from agencies)&nbsp;

The World Health Organisation (WHO) on Wednesday (Jan 10) said that coronavirus (COVID-19) cases last month saw a rise during holiday gatherings globally fuelled by the most prominent variant.

The World Health Organisation (WHO) on Wednesday (Jan 10) said that coronavirus (COVID-19) cases last month saw a rise during holiday gatherings globally fuelled by the most prominent variant. Tedros Adhanom Ghebreyesus, the Director-General of WHO, said that nearly 10,000 deaths were reported in December. Meanwhile, hospital admissions jumped 42 per cent during the month in nearly 50 countries. The cases were mostly reported in Europe and the Americas. "Although 10,000 deaths a month is far less than the peak of the pandemic, this level of preventable deaths is not acceptable," the WHO chief told reporters from its headquarters in Geneva. Also read: Covid kills two in Maharashtra, Karnataka as cases rise due to JN.1 sub-variant WHO chief said that it was "certain" that cases were on the rise in other places that haven't been reporting. He also urged the governments to track Covid cases and provide continued access to treatments and vaccines. According to Tedros, the JN.1 variant was now the most prominent in the world. It is an omicron variant, so current vaccines should still provide some protection. As quoted by The Associated Press, Maria Van Kerkhove, who is the technical lead at WHO for Covid, cited an increase in respiratory diseases across the globe due to the coronavirus but also flu, rhinovirus and pneumonia. While talking about increases in Covid in the southern hemisphere — where it's now summer, she said: "We expect those trends to continue into January through the winter months in the northern hemisphere." Also read: Thailand seeks public opinion as it moves to ban recreational cannabis use, after historic decriminalisation Van Kerkhove further said this year in particular, "we are seeing co-circulation of many different types of pathogens" as she mentioned cough, sniffling, fever and fatigue in the winter are nothing new. Vaccination, wearing masks, and proper ventilation are some of the recommendations given by WHO officials. Dr Michael Ryan, head of emergencies at WHO, said: "The vaccines may not stop you being infected, but the vaccines are certainly reducing significantly your chance of being hospitalized or dying." Watch: At least 300 dead as Congo River basin submerged by generational floods × Mask mandate in Spain The report by WHO comes amid Spain imposing mask mandate in hospitals and other healthcare facilities from Wednesday to curb Covid cases, the health ministry said on Monday as the country faces a flu outbreak. The decree was announced after a meeting between the health ministry and representatives of the country's regions, who control their own health systems. Spanish Health Minister Monica Garcia after the meeting said, "Since the pandemic, we have learnt. We have thought hard about the issue of the mask to protect above all health centres and hospitals, to protect patients as much as (healthcare) professionals." (With inputs from agencies)

COVID-19 during holidays: WHO says nearly 10,000 died due to cases fueled by new variant

New Delhi on Wednesday (Dec 27) reported the first case of JN.1. Official told the news agencies that out of the three samples sent for genome sequencing, one was JN.1, which is a derivative of BA.2.86. Two were Omicron.&nbsp;

Delhi's Health Minister Saurabh Bharadwaj said, "JN.1 is a sub-variant of Omicron and is a mild infection. This is the one spreading in south India. There is no need to panic. It causes mild sickness."&nbsp;

<h2>Covid cases in Delhi&nbsp;</h2>

A Delhi government official told India-based news agency PTI reported that a 28-year-old patient, who had co-morbidities, died. The official claimed that Covid was not the primary reason.&nbsp;

As per the official data, Delhi has around 35 active cases with nine fresh infections being reported on Wednesday, the official further told the news provider.&nbsp;

The official told PTI: "The man was not from Delhi and was referred to a private hospital recently. He had multiple comorbidities and the Covid finding was incidental. The sample of the man has been sent for genome sequencing and a report is awaited."&nbsp;

The official said that the deceased was suffering from multi-system inflammatory syndrome and was "highly comorbid".&nbsp;

"The Covid finding was incidental and mostly it has been seen that patients are referred to Delhi when they are in the last stage of a disease," he added.

Also read:&nbsp;<a href="https://www.wionews.com/india-news/india-declares-muslim-league-jammu-kashmir-an-unlawful-association-674090">India declares Muslim League Jammu Kashmir an 'unlawful association'</a>&nbsp;

Watch:&nbsp;Ammonia leak in Chennai's Tamil Nadu leave at least 34 hospitalised&nbsp;

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/india-ammonia-leak-in-chennais-tamil-nadu-leave-at-least-34-hospitalised-674071/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<h2>JN.1 variant in India&nbsp;</h2>

In India, 40 more cases of the COVID-19 sub-variant JN.1 were recorded. The tally of cases of the new variant across the nation till December 26 has risen to 109, PTI reported earlier on Wednesday citing official sources.&nbsp;

The health ministry said on Wednesday that India recorded 529 fresh Covid cases in a single day, while the country's active infection count stood at 4,093.&nbsp;

Also read:&nbsp;<a href="https://www.wionews.com/world/india-italy-move-forward-in-melodi-era-with-approval-of-key-migration-and-mobility-pact-674079">India-Italy move forward in ‘Melodi’ era with approval of key migration and mobility pact</a>&nbsp;

<h2>Experts on Covid scare in India&nbsp;</h2>

WION recently spoke to Dr Sushila Kataria, Senior Director, Internal Medicine, Medanta, Gurugram. She said that despite its distinct name, the JN.1 variant is not significantly different genetically from the BA variants, and they typically manifest as mild cases.&nbsp;

Talking about preventive measures, Dr Kataria said, "In light of the rising influenza cases, it is crucial to adopt preventive measures. Individuals exhibiting symptoms, regardless of age, should refrain from attending school or work, isolate themselves, wear masks in public spaces, and seek appropriate treatment. Hospital visits are advisable for those experiencing persistent symptoms or difficulties in performing routine activities."&nbsp;

Meanwhile, Dr Ankita Baidya, Consultant Infections Disease, Manipal Hospital, Dwarka told WION that the reasons for the rise are a smaller number of people following Covid appropriate behaviour, and the new strain might be having the ability to evade immunity.&nbsp;

"Watch out for the JN.1 variant in India if you experience fever and chills, abdominal discomfort, nausea, loose motion, or a combination of dry cough and sore throat – these symptoms may indicate infection with this variant. Early recognition and precautions can aid timely intervention and management," Dr Baidya added. &nbsp;

(With inputs from agencies)&nbsp;

New Delhi on Wednesday (Dec 27) reported the first case of JN.1. Official told the news agencies that out of the three samples sent for genome sequencing, one was JN.

New Delhi on Wednesday (Dec 27) reported the first case of JN.1. Official told the news agencies that out of the three samples sent for genome sequencing, one was JN.1, which is a derivative of BA.2.86. Two were Omicron. Delhi's Health Minister Saurabh Bharadwaj said, "JN.1 is a sub-variant of Omicron and is a mild infection. This is the one spreading in south India. There is no need to panic. It causes mild sickness." Covid cases in Delhi A Delhi government official told India-based news agency PTI reported that a 28-year-old patient, who had co-morbidities, died. The official claimed that Covid was not the primary reason. As per the official data, Delhi has around 35 active cases with nine fresh infections being reported on Wednesday, the official further told the news provider. The official told PTI: "The man was not from Delhi and was referred to a private hospital recently. He had multiple comorbidities and the Covid finding was incidental. The sample of the man has been sent for genome sequencing and a report is awaited." The official said that the deceased was suffering from multi-system inflammatory syndrome and was "highly comorbid". "The Covid finding was incidental and mostly it has been seen that patients are referred to Delhi when they are in the last stage of a disease," he added. Also read: India declares Muslim League Jammu Kashmir an 'unlawful association' Watch: Ammonia leak in Chennai's Tamil Nadu leave at least 34 hospitalised × JN.1 variant in India In India, 40 more cases of the COVID-19 sub-variant JN.1 were recorded. The tally of cases of the new variant across the nation till December 26 has risen to 109, PTI reported earlier on Wednesday citing official sources. The health ministry said on Wednesday that India recorded 529 fresh Covid cases in a single day, while the country's active infection count stood at 4,093. Also read: India-Italy move forward in ‘Melodi’ era with approval of key migration and mobility pact Experts on Covid scare in India WION recently spoke to Dr Sushila Kataria, Senior Director, Internal Medicine, Medanta, Gurugram. She said that despite its distinct name, the JN.1 variant is not significantly different genetically from the BA variants, and they typically manifest as mild cases. Talking about preventive measures, Dr Kataria said, "In light of the rising influenza cases, it is crucial to adopt preventive measures. Individuals exhibiting symptoms, regardless of age, should refrain from attending school or work, isolate themselves, wear masks in public spaces, and seek appropriate treatment. Hospital visits are advisable for those experiencing persistent symptoms or difficulties in performing routine activities." Meanwhile, Dr Ankita Baidya, Consultant Infections Disease, Manipal Hospital, Dwarka told WION that the reasons for the rise are a smaller number of people following Covid appropriate behaviour, and the new strain might be having the ability to evade immunity. "Watch out for the JN.1 variant in India if you experience fever and chills, abdominal discomfort, nausea, loose motion, or a combination of dry cough and sore throat – these symptoms may indicate infection with this variant. Early recognition and precautions can aid timely intervention and management," Dr Baidya added. (With inputs from agencies)

New Delhi reports first case of COVID-19 sub-variant JN.1, minister says ‘no need to panic’

India logged a single-day rise of 116 new COVID-19 cases increasing the number of active cases across the country to 4,170 on Tuesday (Dec 26) morning, according to the data from the Indian ministry of health. Meanwhile, health officials in the Indian state of Karnataka will meet later in the day to discuss measures to be taken to manage the Covid situation in the state.

<h2>COVID-19 update</h2>

While India saw a dip in the number of daily COVID-19 cases, on Tuesday morning, the number of active cases has risen,&nbsp;crossing the 4,100 mark.&nbsp;

ALSO READ |&nbsp;<a href="https://www.wionews.com/india-news/delhi-fog-30-flights-delayed-due-to-poor-visibility-as-fog-engulfs-city-5-others-diverted-to-jaipur-673626">Delhi fog: 30 flights delayed due to poor visibility as fog engulfs city; 5 others diverted to Jaipur</a>

India logged a single-day rise of 628 new COVID-19 cases on Monday (Dec 25) prior to a dip on Tuesday. Meanwhile, the number of people who have recovered from the disease has increased to 4,44,72,153, according to the health ministry data posted at 8:00 am (local time) on December 26.

<h2>Situation in Karnataka</h2>

Karnataka Health Minister Dinesh Gundu Rao, on Monday, said that the state government’s cabinet sub-committee will meet on Tuesday to discuss the recommendations made by the Technical Advisory Committee (TAC) on further measures to be taken to manage the COVID-19 situation.

“As we increase Covid tests, cases will increase. Our TAC has met yesterday and has held discussions, the cabinet sub-committee which is meeting tomorrow will look into their suggestions or recommendations and decide on what further measures need to be taken,” said Rao.&nbsp;

ALSO READ |&nbsp;<a href="https://www.wionews.com/india-news/active-covid-cases-in-india-cross-4000-fresh-infections-at-628-673278">Active Covid cases in India cross 4,000; fresh infections at 628</a>

He also indicated that there are no restrictions imposed as of now but urged people to be cautious and take precautions. “Nowhere in the country or world there is any restriction, despite JN.1 subvariant prevalent everywhere. There are no such guidelines from the central government or the World Health Organisation,” Rao added.&nbsp;

The state government recently constituted a four-member cabinet sub-committee headed by Rao for COVID-19 management amid an uptick in the number of infections recorded in the state.&nbsp;

Karnataka has logged a single-day rise of 92 COVID-19 cases&nbsp;on Tuesday, taking the number of active cases in the state to 436.&nbsp;

<h2>63 JN.1 cases in India</h2>

At least 63 cases of JN.1, the new COVID-19 sub-variant, had been reported across the country, as of&nbsp;Sunday with the highest in the Indian state of Goa.&nbsp;

Goa has reported 34 cases of the new Covid subvariant, while nine other cases have been detected in Maharashtra, eight in Karnataka, six in Kerala, four in Tamil Nadu, and two from Telangana, according to the Indian ministry of health.&nbsp;

ALSO READ |&nbsp;<a href="https://www.wionews.com/india-news/indian-navy-set-to-commission-ins-imphal-today-seven-key-facts-to-note-673582">Indian Navy set to commission INS Imphal today, seven key facts to note</a>

However, in an update on Monday, the Karnataka Department of Health and Family Welfare Services said it recorded 34 cases of the JN.1 variant, including three deaths, reported news agency PTI.&nbsp;

The World Health Organization (WHO) on Tuesday (Dec 19) announced that it would step up its classification of the new COVID-19 variant JN.1 to a standalone “variant of interest”.&nbsp;

(With inputs from agencies)

India logged a single-day rise of 116 new COVID-19 cases increasing the number of active cases across the country to 4,170 on Tuesday (Dec 26) morning, according to the data from the Indian ministry of health.

India logged a single-day rise of 116 new COVID-19 cases increasing the number of active cases across the country to 4,170 on Tuesday (Dec 26) morning, according to the data from the Indian ministry of health. Meanwhile, health officials in the Indian state of Karnataka will meet later in the day to discuss measures to be taken to manage the Covid situation in the state. COVID-19 update While India saw a dip in the number of daily COVID-19 cases, on Tuesday morning, the number of active cases has risen, crossing the 4,100 mark. ALSO READ | Delhi fog: 30 flights delayed due to poor visibility as fog engulfs city; 5 others diverted to Jaipur India logged a single-day rise of 628 new COVID-19 cases on Monday (Dec 25) prior to a dip on Tuesday. Meanwhile, the number of people who have recovered from the disease has increased to 4,44,72,153, according to the health ministry data posted at 8:00 am (local time) on December 26. Situation in Karnataka Karnataka Health Minister Dinesh Gundu Rao, on Monday, said that the state government’s cabinet sub-committee will meet on Tuesday to discuss the recommendations made by the Technical Advisory Committee (TAC) on further measures to be taken to manage the COVID-19 situation. “As we increase Covid tests, cases will increase. Our TAC has met yesterday and has held discussions, the cabinet sub-committee which is meeting tomorrow will look into their suggestions or recommendations and decide on what further measures need to be taken,” said Rao. ALSO READ | Active Covid cases in India cross 4,000; fresh infections at 628 He also indicated that there are no restrictions imposed as of now but urged people to be cautious and take precautions. “Nowhere in the country or world there is any restriction, despite JN.1 subvariant prevalent everywhere. There are no such guidelines from the central government or the World Health Organisation,” Rao added. The state government recently constituted a four-member cabinet sub-committee headed by Rao for COVID-19 management amid an uptick in the number of infections recorded in the state. Karnataka has logged a single-day rise of 92 COVID-19 cases on Tuesday, taking the number of active cases in the state to 436. 63 JN.1 cases in India At least 63 cases of JN.1, the new COVID-19 sub-variant, had been reported across the country, as of Sunday with the highest in the Indian state of Goa. Goa has reported 34 cases of the new Covid subvariant, while nine other cases have been detected in Maharashtra, eight in Karnataka, six in Kerala, four in Tamil Nadu, and two from Telangana, according to the Indian ministry of health. ALSO READ | Indian Navy set to commission INS Imphal today, seven key facts to note However, in an update on Monday, the Karnataka Department of Health and Family Welfare Services said it recorded 34 cases of the JN.1 variant, including three deaths, reported news agency PTI. The World Health Organization (WHO) on Tuesday (Dec 19) announced that it would step up its classification of the new COVID-19 variant JN.1 to a standalone “variant of interest”. (With inputs from agencies)

India logs 116 new COVID-19 cases in 24 hours; number of active cases rises to 4,170

2023 was a memorable year for India a year after enduring severe disruptions caused by the COVID-19 pandemic and the war between Russia and Ukraine the global economy finally started showing signs of recovery in 2023. In the next report, we take a look at India world's fifth-largest economy how it remained buoyant in the year 2023.

WION Rewind India's moments of glory: Indian economy remain buoyant after COVID-19

In a concerning development, India witnessed a spike in COVID-19 cases with 640 new infections reported on Friday, pushing the active cases to 2,997. The total COVID-19 tally in the country now stands at a staggering 4.50 crore (4,50,07,212), with the death toll reaching 5,33,328.

Covid-19 JN.1 variant : 2997 active cases of covid in India, highest surge in Kerala

In a rare case, a healthy teenage girl suddenly complained about facing trouble breathing, days after a SARS-CoV-2 infection. As per doctors, the girl's vocal cords were paralysed by the COVID-19. 
 
After the diagnosis, the girl had to undergo a surgical tracheostomy – in which an opening was made in her windpipe which was below her voice box – to support her breath.

As per the event's new case report, the impact of COVID-19 on the nervous system may lead to paralysis of the vocal cord in rare cases. The authors said that this is the first case of a teenager suffering vocal cord paralysis after she was diagnosed with COVID-19, although there were reports of adults suffering from similar conditions.

Also read:&nbsp;<a href="https://www.wionews.com/india-news/covid-scare-returns-with-jn1-rearing-its-head-do-you-need-to-worry-experts-speak-671776">Covid scare returns: With JN.1 spreading fast, do you need to worry? Experts speak</a>

"The virus has known neurologic complications, including headache, seizure, and peripheral neuropathy," said otolaryngologists Danielle Larrow and Christopher Hartnick from Mass Eye and Ear at Harvard Medical School. 
 
"The current case reveals that vocal cord paralysis may be an additional neuropathic sequela of the virus,” he added.

<h2>Doctors investigate girl's symptoms</h2>

Thirteen days after the 15-year-old girl tested positive for SARS-CoV-2, she was taken to the hospital emergency department. Her initial symptoms were fever, congestion and fatigue, which improved after five days. However, after nine days of getting tested, she said that she is facing trouble breathing, especially when she is active. 
 
It was noted by emergency department doctors that her breathing was rapid and noisy while inhaling, which indicated obstructed airflow, although her oxygen levels remained normal. Tests for respiratory infections, including SARS-CoV-2, came negative. 
 
The girl, who had a history of anxiety and asthma, was given bronchodilators and steroids for a suspected asthma attack, however, that didn't help.

Watch:&nbsp;Covid-19 makes global comeback; new Omicron sub-variant JN.1 causes global concern&nbsp;

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/covid-19-makes-global-comeback-new-omicron-sub-variant-jn1-causes-global-concern-wion-671372/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

Her vocal cords were examined by the otolaryngologists and she was diagnosed with paradoxical vocal fold motion (PVFM), in which the vocal cords close instead of opening when a person tries to breathe. 
 
The girl started undergoing speech therapy to treat the involuntary closure, however, there were no improvements in her symptoms and it became clear that they failed to match the typical signs of PVFM. 
 
Her vocal cords were examined again by the otolaryngologists and this time, the girl was diagnosed with bilateral vocal cord paralysis, which meant both her vocal cords were not moving. 
 
On the basis of their findings, the doctors said that the previous COVID-19 infection of the teenager may have weakened her vocal cords and may have also led to numbness and weakness on one side.

(With inputs from agencies)

In a rare case, a healthy teenage girl suddenly complained about facing trouble breathing, days after a SARS-CoV-2 infection. As per doctors, the girl's vocal cords were paralysed by the COVID-19.

In a rare case, a healthy teenage girl suddenly complained about facing trouble breathing, days after a SARS-CoV-2 infection. As per doctors, the girl's vocal cords were paralysed by the COVID-19. After the diagnosis, the girl had to undergo a surgical tracheostomy – in which an opening was made in her windpipe which was below her voice box – to support her breath. As per the event's new case report, the impact of COVID-19 on the nervous system may lead to paralysis of the vocal cord in rare cases. The authors said that this is the first case of a teenager suffering vocal cord paralysis after she was diagnosed with COVID-19, although there were reports of adults suffering from similar conditions. Also read: Covid scare returns: With JN.1 spreading fast, do you need to worry? Experts speak "The virus has known neurologic complications, including headache, seizure, and peripheral neuropathy," said otolaryngologists Danielle Larrow and Christopher Hartnick from Mass Eye and Ear at Harvard Medical School. "The current case reveals that vocal cord paralysis may be an additional neuropathic sequela of the virus,” he added. Doctors investigate girl's symptoms Thirteen days after the 15-year-old girl tested positive for SARS-CoV-2, she was taken to the hospital emergency department. Her initial symptoms were fever, congestion and fatigue, which improved after five days. However, after nine days of getting tested, she said that she is facing trouble breathing, especially when she is active. It was noted by emergency department doctors that her breathing was rapid and noisy while inhaling, which indicated obstructed airflow, although her oxygen levels remained normal. Tests for respiratory infections, including SARS-CoV-2, came negative. The girl, who had a history of anxiety and asthma, was given bronchodilators and steroids for a suspected asthma attack, however, that didn't help. Watch: Covid-19 makes global comeback; new Omicron sub-variant JN.1 causes global concern Her vocal cords were examined by the otolaryngologists and she was diagnosed with paradoxical vocal fold motion (PVFM), in which the vocal cords close instead of opening when a person tries to breathe. The girl started undergoing speech therapy to treat the involuntary closure, however, there were no improvements in her symptoms and it became clear that they failed to match the typical signs of PVFM. Her vocal cords were examined again by the otolaryngologists and this time, the girl was diagnosed with bilateral vocal cord paralysis, which meant both her vocal cords were not moving. On the basis of their findings, the doctors said that the previous COVID-19 infection of the teenager may have weakened her vocal cords and may have also led to numbness and weakness on one side. (With inputs from agencies)

COVID-19 infection paralyses vocal cords of teenager, first such case to be reported in world

After Kerala, JN.1 variant has now been found in Goa. 21 new cases have been reported in India in the last 24 hours which makes it 2,669 active cases. Singapore has become a country of concern, Indonesia is asking travellers to be vigilant. In Malaysia, cases have doubled. This is December Deja Vu.

Covid-19 India: 2,669 active cases of Covid in India, highest surge in Kerala

India has seen an uptick in the coronavirus (COVID-19) cases in the last few days, which has caused panic among citizens. But the government agencies have said that there's no need to panic.&nbsp;

India's southern state of Kerala has reported a case of Covid with the JN.1 variant, which is a derivative of BA.2.86.&nbsp;

Local authorities said that a 79-year-old woman was detected with JN.1 infection in the Karakulam area of Thiruvananthapuram district of the state on December 8, but it also mentioned that she has been fully recovered.&nbsp;

Kerala has reported a spike in Covid cases, with three deaths in the last 24 hours. Overall, there are more than 2,000 active cases in India, health ministry's data showed.&nbsp;

The World Health Organization (WHO) on Tuesday (Dec &nbsp;19) also announced that it would step up its classification of the new COVID-19 variant JN.1 to a standalone "variant of interest".&nbsp;

Dr RR Dutta, HOD Internal Medicine, Paras Health, Gurugram, told WION that the emergence of the JN.1 strain of Covid has caused "considerable concern globally".&nbsp;

Kerala's instance was identified via genetic analysis, with no documented cases of hospitalisations or severe illnesses at present, which has helped ease immediate concerns. The condition is being carefully observed and supervised, Dr Dutta added.&nbsp;

Also read:&nbsp;<a href="https://www.wionews.com/india-news/india-high-level-review-meet-held-by-health-minister-amid-escalating-covid-19-cases-671611">High-level review meet held by health minister amid escalating COVID-19 cases</a>&nbsp;

<h2>What are ṭhe symptoms?&nbsp;</h2>

The variant is characterised by increased transmissibility, its symptoms overlap with other viral infections, including fever, cough, runny nose, shortness of breath, fatigue, body aches, sore throat, mild gastrointestinal symptoms, and loss of taste or smell.&nbsp;

"These symptoms may resemble other upper respiratory infections caused by seasonal viruses," Dr Dutta added.&nbsp;

Dr Sushila Kataria, Senior Director, Internal Medicine, Medanta, Gurugram told WION that despite its distinct name, the JN.1 variant is not significantly different genetically from the BA variants, and they typically manifest as mild cases.&nbsp;

Also read:&nbsp;<a href="https://www.wionews.com/health-and-wellness/pollution-makes-respiratory-illnesses-worse-in-winter-season-what-should-be-preventive-approach-671460">Pollution makes respiratory illnesses worse in winter season: What should be preventive approach?</a>&nbsp;

<h2>What should be preventive measures in India?&nbsp;</h2>

Crucial preventive measures include vaccination, mask-wearing, hand hygiene, and social distancing.&nbsp;

It is also important to understand its contagious nature, which underscores the urgency for adhering to safety protocols.&nbsp;

Dr Sushila Kataria said, "In light of the rising influenza cases, it is crucial to adopt preventive measures. Individuals exhibiting symptoms, regardless of age, should refrain from attending school or work, isolate themselves, wear masks in public spaces, and seek appropriate treatment. Hospital visits are advisable for those experiencing persistent symptoms or difficulties in performing routine activities."&nbsp;

She also said that preventive actions include securing the seasonal flu vaccination for everyone, with consideration for the pneumonia vaccine, especially for individuals with comorbidities or those aged above 65.&nbsp;

Watch:&nbsp;India: 2,311 active Covid cases, highest surge in Kerala; 341 new JN.1 Covid strain cases&nbsp;

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/india-2311-active-covid-cases-highest-surge-in-kerala-341-new-jn1-covid-strain-cases-wion-671755/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

She said, "Concerning COVID vaccination, those who have not yet received it should undergo vaccination, with the expectation of having completed three doses by now. While the necessity of annual COVID vaccination is not clearly outlined, awaiting guidance from AICMR or DCGI is recommended for clarity."&nbsp;

"Presently, the risk of escalation appears minimal due to the similarities between the JN.1 and BA variants. Nevertheless, exercising caution and following preventive measures remain advisable," she added.&nbsp;

A high-level meeting was held on Wednesday (Dec 20), headed by Dr Mansukh Mandaviya, who is India's Union Minister of Health and Family Welfare. The meeting was aimed at reviewing the current Covid situation in India and the preparedness of the public health system for surveillance, containment and management of the deadly disease.&nbsp;&nbsp;

Dr Ankita Baidya, Consultant Infections Disease, Manipal Hospital, Dwarka told WION that the reasons for the rise are a smaller number of people following Covid appropriate behaviour, and the new strain might be having ability to evade immunity.

"Watch out for the JN.1 variant in India if you experience fever and chills, abdominal discomfort, nausea, loose motion, or a combination of dry cough and sore throat – these symptoms may indicate infection with this variant. Early recognition and precautions can aid timely intervention and management," Dr Baidya added.&nbsp;

India has seen an uptick in the coronavirus (COVID-19) cases in the last few days, which has caused panic among citizens. But the government agencies have said that there's no need to panic.

India has seen an uptick in the coronavirus (COVID-19) cases in the last few days, which has caused panic among citizens. But the government agencies have said that there's no need to panic. India's southern state of Kerala has reported a case of Covid with the JN.1 variant, which is a derivative of BA.2.86. Local authorities said that a 79-year-old woman was detected with JN.1 infection in the Karakulam area of Thiruvananthapuram district of the state on December 8, but it also mentioned that she has been fully recovered. Kerala has reported a spike in Covid cases, with three deaths in the last 24 hours. Overall, there are more than 2,000 active cases in India, health ministry's data showed. The World Health Organization (WHO) on Tuesday (Dec 19) also announced that it would step up its classification of the new COVID-19 variant JN.1 to a standalone "variant of interest". Dr RR Dutta, HOD Internal Medicine, Paras Health, Gurugram, told WION that the emergence of the JN.1 strain of Covid has caused "considerable concern globally". Kerala's instance was identified via genetic analysis, with no documented cases of hospitalisations or severe illnesses at present, which has helped ease immediate concerns. The condition is being carefully observed and supervised, Dr Dutta added. Also read: High-level review meet held by health minister amid escalating COVID-19 cases What are ṭhe symptoms? The variant is characterised by increased transmissibility, its symptoms overlap with other viral infections, including fever, cough, runny nose, shortness of breath, fatigue, body aches, sore throat, mild gastrointestinal symptoms, and loss of taste or smell. "These symptoms may resemble other upper respiratory infections caused by seasonal viruses," Dr Dutta added. Dr Sushila Kataria, Senior Director, Internal Medicine, Medanta, Gurugram told WION that despite its distinct name, the JN.1 variant is not significantly different genetically from the BA variants, and they typically manifest as mild cases. Also read: Pollution makes respiratory illnesses worse in winter season: What should be preventive approach? What should be preventive measures in India? Crucial preventive measures include vaccination, mask-wearing, hand hygiene, and social distancing. It is also important to understand its contagious nature, which underscores the urgency for adhering to safety protocols. Dr Sushila Kataria said, "In light of the rising influenza cases, it is crucial to adopt preventive measures. Individuals exhibiting symptoms, regardless of age, should refrain from attending school or work, isolate themselves, wear masks in public spaces, and seek appropriate treatment. Hospital visits are advisable for those experiencing persistent symptoms or difficulties in performing routine activities." She also said that preventive actions include securing the seasonal flu vaccination for everyone, with consideration for the pneumonia vaccine, especially for individuals with comorbidities or those aged above 65. Watch: India: 2,311 active Covid cases, highest surge in Kerala; 341 new JN.1 Covid strain cases × She said, "Concerning COVID vaccination, those who have not yet received it should undergo vaccination, with the expectation of having completed three doses by now. While the necessity of annual COVID vaccination is not clearly outlined, awaiting guidance from AICMR or DCGI is recommended for clarity." "Presently, the risk of escalation appears minimal due to the similarities between the JN.1 and BA variants. Nevertheless, exercising caution and following preventive measures remain advisable," she added. A high-level meeting was held on Wednesday (Dec 20), headed by Dr Mansukh Mandaviya, who is India's Union Minister of Health and Family Welfare. The meeting was aimed at reviewing the current Covid situation in India and the preparedness of the public health system for surveillance, containment and management of the deadly disease. Dr Ankita Baidya, Consultant Infections Disease, Manipal Hospital, Dwarka told WION that the reasons for the rise are a smaller number of people following Covid appropriate behaviour, and the new strain might be having ability to evade immunity. "Watch out for the JN.1 variant in India if you experience fever and chills, abdominal discomfort, nausea, loose motion, or a combination of dry cough and sore throat – these symptoms may indicate infection with this variant. Early recognition and precautions can aid timely intervention and management," Dr Baidya added.

Covid scare returns: With JN.1 spreading fast, do you need to worry? Experts speak

The COVID scare does not seem to go away four years since China reported its first case and new variants are still circulating globally. The Indian government has now confirmed the presence of JN.1 subvariant of COVID-19 in the southern state of Kerala.

Variant JN.1: New Covid variant detected in India's Kerela

Covid variant JN.1 in India: Masks mandatory for everyone aged 60 & over in Karnataka

COVID-19 doesn’t seem to be in the mood&nbsp;to leave us alone anytime soon, as new variants keep popping up now and then. One such new subvariant of the virus, JN.1 that raised concerns in the US has now been detected in the Indian state of Kerala. Meanwhile, the US continues to see the emergence of new Covid variants and is now struggling to bring the HV.1 variant under control.

JN.1, a descendant of Pirola or BA.2.86, increased worries for Kerala’s healthcare system as it was detected for the first time in the state, dodging India’s genome surveillance efforts. The new variant can have a potential impact on the already-rising cases in the state, as per experts.

Now the Indian government has issued an advisory for all the Indian states to stay alert amid the rising number of cases. Winter especially is a time when the virus starts rearing its head again. &nbsp;

Also Read |&nbsp;<a href="https://www.wionews.com/india-news/smriti-irani-opposes-menstruation-leave-policy-says-its-not-handicap-669398">Smriti Irani opposes menstruation leave policy, says it's 'not handicap'</a>

<h2>New COVID-19 subvariant&nbsp;JN.1 detected in Kerala</h2>

The presence of the latest subvariant in Kerala was confirmed by the Indian SARS-CoV-2 Genomics Consortium (INSACOG).&nbsp;

Dr Rajeeb Jayadevan, co-chairman, of the National Indian Medical Association (IMA) Covid Task Force, said JN.1 could be a contributing factor in the recent surge in COVID-19 cases in India, specifically in Kerala.&nbsp;

Also Read |&nbsp;<a href="https://www.wionews.com/india-news/indian-parliament-security-breach-who-is-bjp-mp-pratap-simha-who-issued-passes-to-the-intruders-669463">Indian Parliament security breach: Who is BJP MP Pratap Simha who issued passes to the intruders?</a>

India’s active case count has reached 938, with Kerala recording the highest number of patients, a total of 768.

The new variant was first detected in Europe in August 2023. Luxembourg reported the first case of the new variant, followed by England, Iceland, France and the US. The scientists in the US found the JN.1 variant to be more infectious as it can evade vaccine immunity.&nbsp;

<h2>US grappling with HV.1 now</h2>

Meanwhile, the United States is now seeing another increase in the number of Covid cases owing to the HV.1 variant. The country is already going through the respiratory virus season and Covid is making matters worse. After JN.1 and&nbsp;EG.5 or&nbsp;Eris,&nbsp;HV.1 has become the dominant variant in the county and accounts for an estimated one-third of cases nationwide.&nbsp;

HV.1 rapidly started spreading in October and November.&nbsp;

As per the&nbsp;Centers for Disease Control and Prevention, HV.1 accounts for&nbsp;nearly 30 per cent&nbsp;of new COVID-19 infections in the US, while JN.1 makes up around 21 per cent of new COVID-19 cases.

Experts say that the number of new cases is expected to grow with the winter season kicking in.&nbsp;&nbsp;

<h2>Decoding JN.1, the new COVID-19 variant</h2>

JN.1 is a descendant of the Omicron subvariant BA.2.86. The World Health Organization (WHO) has identified it as a “notable descendant lineage” of Omicron, indicating its potential for increased transmissibility or immune evasion.&nbsp;

JN.1 carries a mutation that gives it extra immune-evading capabilities. The preprint paper testing how the new vaccines performed against HV.1 also showed that they produced antibodies effective against JN.1, but not as many.

Signs and symptoms

Symptoms of JN.1 subvariant include-

Fever

Coughing

Tiredness

Nasal congestion

Runny nose

Diarrhea

Headaches

(With inputs from agencies)

COVID-19 doesn’t seem to be in the mood to leave us alone anytime soon, as new variants keep popping up now and then. One such new subvariant of the virus, JN.1 that raised concerns in the US has now been detected in the Indian state of Kerala.

COVID-19 doesn’t seem to be in the mood to leave us alone anytime soon, as new variants keep popping up now and then. One such new subvariant of the virus, JN.1 that raised concerns in the US has now been detected in the Indian state of Kerala. Meanwhile, the US continues to see the emergence of new Covid variants and is now struggling to bring the HV.1 variant under control. JN.1, a descendant of Pirola or BA.2.86, increased worries for Kerala’s healthcare system as it was detected for the first time in the state, dodging India’s genome surveillance efforts. The new variant can have a potential impact on the already-rising cases in the state, as per experts. Now the Indian government has issued an advisory for all the Indian states to stay alert amid the rising number of cases. Winter especially is a time when the virus starts rearing its head again. Also Read | Smriti Irani opposes menstruation leave policy, says it's 'not handicap' New COVID-19 subvariant JN.1 detected in Kerala The presence of the latest subvariant in Kerala was confirmed by the Indian SARS-CoV-2 Genomics Consortium (INSACOG). Dr Rajeeb Jayadevan, co-chairman, of the National Indian Medical Association (IMA) Covid Task Force, said JN.1 could be a contributing factor in the recent surge in COVID-19 cases in India, specifically in Kerala. Also Read | Indian Parliament security breach: Who is BJP MP Pratap Simha who issued passes to the intruders? India’s active case count has reached 938, with Kerala recording the highest number of patients, a total of 768. The new variant was first detected in Europe in August 2023. Luxembourg reported the first case of the new variant, followed by England, Iceland, France and the US. The scientists in the US found the JN.1 variant to be more infectious as it can evade vaccine immunity. US grappling with HV.1 now Meanwhile, the United States is now seeing another increase in the number of Covid cases owing to the HV.1 variant. The country is already going through the respiratory virus season and Covid is making matters worse. After JN.1 and EG.5 or Eris, HV.1 has become the dominant variant in the county and accounts for an estimated one-third of cases nationwide. HV.1 rapidly started spreading in October and November. As per the Centers for Disease Control and Prevention, HV.1 accounts for nearly 30 per cent of new COVID-19 infections in the US, while JN.1 makes up around 21 per cent of new COVID-19 cases. Experts say that the number of new cases is expected to grow with the winter season kicking in. Decoding JN.1, the new COVID-19 variant JN.1 is a descendant of the Omicron subvariant BA.2.86. The World Health Organization (WHO) has identified it as a “notable descendant lineage” of Omicron, indicating its potential for increased transmissibility or immune evasion. JN.1 carries a mutation that gives it extra immune-evading capabilities. The preprint paper testing how the new vaccines performed against HV.1 also showed that they produced antibodies effective against JN.1, but not as many. Signs and symptoms Symptoms of JN.1 subvariant include- Fever Coughing Tiredness Nasal congestion Runny nose Diarrhea Headaches (With inputs from agencies)

JN.1 in India and HV.1 in US, Covid doesn't seem to be giving us a break

Almost half of the people known to have contracted COVID-19 in Africa are now living with the effects of long Covid, according to a recent analysis published in Scientific Reports. The research conducted by a team of scientists from Italy found that the incidence rates in African nations are the highest among any of the other low-income countries.&nbsp;

<h2>About the study</h2>

Long Covid has been defined as a condition where symptoms of being infected with the SARS-CoV-2 virus persist for three months or more. The research was conducted by a team of scientists from the University of Bari, Italy, and analysed the data of 29,213 people.&nbsp;

According to the study, researchers found that globally, at least 10 per cent of people infected with COVID-19 have this condition.&nbsp;

ALSO READ |&nbsp;<a href="https://www.wionews.com/world/tired-of-battling-long-covid-canadian-woman-applies-for-euthanasia-669973">Tired of battling long Covid, Canadian woman applies for euthanasia</a>

Following the comprehensive review of previous studies and analysis scientists also found that the estimates of incidence among low-income countries long Covid varies greatly. This has been attributed to hidden infections and the difficulty of accessing tests.

For example, among African nations, estimates range from two per cent in Ghana to a staggering 86 per cent in Egypt. The review also found that older people are more likely to experience long Covid, but did not find any significant difference between men and women at risk for the condition.&nbsp;

Cognitive impairment, according to the study, was the most common neurologic symptom of long Covid, while shortness of breath was the most common respiratory symptom. A quarter of those suffering from long Covid have reported post-traumatic stress disorder (PTSD).

The researchers noted how this particular finding was “concerning” since it adds an additional burden in mental health disorder brought on by the COVID-19 pandemic and its chronic consequences have been put on a health system which is largely unprepared to deal with mental health conditions.&nbsp;

The team also found that a quarter of people with long Covid had a poor quality of life as a result, with fatigue and loss of appetite.&nbsp;

<h2>What is happening in Africa?</h2>

The high rate of estimated incidence of long Covid, particularly in African nations, has been attributed to the fact that less than 52 per cent of people are fully vaccinated, said the researchers. However, specific data on vaccination status and COVID-19 outcomes are largely unknown from the continent.&nbsp;

ALSO READ |&nbsp;<a href="https://www.wionews.com/science/study-reveals-organ-damage-in-long-covid-patients-who-required-hospitalisation-638826">Study reveals organ damage in long covid patients who required hospitalisation</a>

“To our knowledge, this is the first meta-analysis exploring prevalence, risk factors and symptomatology of long COVID in Africa,” the researchers wrote. The team has also urged for further research so that experts can properly assess the impact of long Covid in the African continent.&nbsp;

They also called on raising awareness of how prevalent this condition might be given the lack of a cure for long Covid, it may be able to help those affected.&nbsp;

(With inputs from agencies)

Almost half of the people known to have contracted COVID-19 in Africa are now living with the effects of long Covid, according to a recent analysis published in Scientific Reports.

Almost half of the people known to have contracted COVID-19 in Africa are now living with the effects of long Covid, according to a recent analysis published in Scientific Reports. The research conducted by a team of scientists from Italy found that the incidence rates in African nations are the highest among any of the other low-income countries. About the study Long Covid has been defined as a condition where symptoms of being infected with the SARS-CoV-2 virus persist for three months or more. The research was conducted by a team of scientists from the University of Bari, Italy, and analysed the data of 29,213 people. According to the study, researchers found that globally, at least 10 per cent of people infected with COVID-19 have this condition. ALSO READ | Tired of battling long Covid, Canadian woman applies for euthanasia Following the comprehensive review of previous studies and analysis scientists also found that the estimates of incidence among low-income countries long Covid varies greatly. This has been attributed to hidden infections and the difficulty of accessing tests. For example, among African nations, estimates range from two per cent in Ghana to a staggering 86 per cent in Egypt. The review also found that older people are more likely to experience long Covid, but did not find any significant difference between men and women at risk for the condition. Cognitive impairment, according to the study, was the most common neurologic symptom of long Covid, while shortness of breath was the most common respiratory symptom. A quarter of those suffering from long Covid have reported post-traumatic stress disorder (PTSD). The researchers noted how this particular finding was “concerning” since it adds an additional burden in mental health disorder brought on by the COVID-19 pandemic and its chronic consequences have been put on a health system which is largely unprepared to deal with mental health conditions. The team also found that a quarter of people with long Covid had a poor quality of life as a result, with fatigue and loss of appetite. What is happening in Africa? The high rate of estimated incidence of long Covid, particularly in African nations, has been attributed to the fact that less than 52 per cent of people are fully vaccinated, said the researchers. However, specific data on vaccination status and COVID-19 outcomes are largely unknown from the continent. ALSO READ | Study reveals organ damage in long covid patients who required hospitalisation “To our knowledge, this is the first meta-analysis exploring prevalence, risk factors and symptomatology of long COVID in Africa,” the researchers wrote. The team has also urged for further research so that experts can properly assess the impact of long Covid in the African continent. They also called on raising awareness of how prevalent this condition might be given the lack of a cure for long Covid, it may be able to help those affected. (With inputs from agencies)

Nearly 50% of those who contracted COVID-19 in Africa are suffering from long Covid: Study

India: Kerala records India's first case of JN.1 sub-variant of COVID-19

The latest research by the University of Bristol suggests that an HIV drug could stop many coronavirus diseases, including the SARS-CoV-2 variants. The study mentioned that the process could deliver results when given to infected cells at the right concentration.&nbsp;

The findings, published in the study Antiviral Research on December 5, stated that the drug has the potential to expand the existing arsenal of medications to combat current and future coronavirus epidemics.&nbsp;

The research team has previously shown that a booster drug (cobicistat) could have antiviral properties against a SARS-CoV-2 variant circulating in Europe in early 2020. The drug is normally used to reinforce the effect of anti-HIV drugs.&nbsp;

Also read:&nbsp;<a href="https://www.wionews.com/science/scientists-say-they-can-predict-organs-age-through-a-blood-test-667209">Scientists say they can ‘predict’ age of organs through a blood test</a>&nbsp;

The researchers have studied whether or not the anti-SARS-CoV-2 properties of cobicistat were maintained against the key variants of concern (VOCs) of SARS-CoV-2 and other coronaviruses, including Middle East respiratory syndrome coronavirus (MERS-CoV).&nbsp;

MERS-CoV is spread over the Middle East, Africa, and South Asia, with a fatality rate of over 30 per cent with no vaccine or specialised treatments now available.

The researchers also compared cobicistat's effects to those of ritonavir, which is a structurally related chemical that is also one of the components of Paxlovid.&nbsp;

Notably, Paxlovid&nbsp;is the current gold standard for antiviral treatment of SARS-CoV-2.

Also read:&nbsp;<a href="https://www.wionews.com/science/ancient-egyptians-didnt-treat-the-baboons-right-and-we-have-proof-667225">Ancient Egypt's sacred baboons were not treated right, and we have proof</a>

To carry out the research, the team used automated image analysis for a screening and parallel comparison of the anti-coronavirus effects of cobicistat and ritonavir.&nbsp;

They found that cobicistat and ritonavir both act against all eight VOCs of SARS-CoV-2 that were tested against other human coronaviruses. The study noted that cobicistat is more powerful than ritonavir.&nbsp;

"Both drugs displayed anti-coronavirus activity in vitro at dosages that are well tolerated, but higher than those currently used for booster activity of anti-HIV drugs and in Paxlovid," the study noted.&nbsp;

Dr Iart Luca Shytaj, Lecturer in the School of Cellular and Molecular Medicine and one of the paper's corresponding authors, said: "Our results indicate that cobicistat, at dosages above its typical clinical use as a booster, could become an effective antiviral drug both on its own and in combination with other antivirals and lead to more potent treatments than current available options."&nbsp;

"If our findings are confirmed in animal and clinical studies, our results could strengthen the arsenal of antiviral drugs in the fight against current and future outbreaks of coronaviruses and reduce their impact on public health globally," Shytaj added.&nbsp;

The latest research by the University of Bristol suggests that an HIV drug could stop many coronavirus diseases, including the SARS-CoV-2 variants. The study mentioned that the process could deliver results when given to infected cells at the right concentration.

The latest research by the University of Bristol suggests that an HIV drug could stop many coronavirus diseases, including the SARS-CoV-2 variants. The study mentioned that the process could deliver results when given to infected cells at the right concentration. The findings, published in the study Antiviral Research on December 5, stated that the drug has the potential to expand the existing arsenal of medications to combat current and future coronavirus epidemics. The research team has previously shown that a booster drug (cobicistat) could have antiviral properties against a SARS-CoV-2 variant circulating in Europe in early 2020. The drug is normally used to reinforce the effect of anti-HIV drugs. Also read: Scientists say they can ‘predict’ age of organs through a blood test The researchers have studied whether or not the anti-SARS-CoV-2 properties of cobicistat were maintained against the key variants of concern (VOCs) of SARS-CoV-2 and other coronaviruses, including Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV is spread over the Middle East, Africa, and South Asia, with a fatality rate of over 30 per cent with no vaccine or specialised treatments now available. The researchers also compared cobicistat's effects to those of ritonavir, which is a structurally related chemical that is also one of the components of Paxlovid. Notably, Paxlovid is the current gold standard for antiviral treatment of SARS-CoV-2. Also read: Ancient Egypt's sacred baboons were not treated right, and we have proof To carry out the research, the team used automated image analysis for a screening and parallel comparison of the anti-coronavirus effects of cobicistat and ritonavir. They found that cobicistat and ritonavir both act against all eight VOCs of SARS-CoV-2 that were tested against other human coronaviruses. The study noted that cobicistat is more powerful than ritonavir. "Both drugs displayed anti-coronavirus activity in vitro at dosages that are well tolerated, but higher than those currently used for booster activity of anti-HIV drugs and in Paxlovid," the study noted. Dr Iart Luca Shytaj, Lecturer in the School of Cellular and Molecular Medicine and one of the paper's corresponding authors, said: "Our results indicate that cobicistat, at dosages above its typical clinical use as a booster, could become an effective antiviral drug both on its own and in combination with other antivirals and lead to more potent treatments than current available options." "If our findings are confirmed in animal and clinical studies, our results could strengthen the arsenal of antiviral drugs in the fight against current and future outbreaks of coronaviruses and reduce their impact on public health globally," Shytaj added.

HIV drug could prevent coronaviruses, if given at right concentration: Study

Former British prime minister Boris Johnson reportedly asked the security services to chalk out plans to raid the Dutch Covid vaccine factory in Leiden.&nbsp;

UK-based Daily Mail newspaper reported citing diplomatic sources that Johnson made the call after saying the EU "stole" millions of AstraZeneca doses destined for Britain during the coronavirus (COVID-19) pandemic.&nbsp;

Notably, the AstraZeneca vaccine was produced at two locations in the EU – the Netherlands and Belgium.&nbsp;

The report added that the idea was dropped as the diplomats apparently warned that such an action would jeopardise the relations between both countries.&nbsp;

Also read:&nbsp;<a href="https://www.wionews.com/world/wales-29-year-old-stabbed-in-village-of-aberfan-manhunt-underway-666581">29-year-old stabbed in village of Aberfan, manhunt underway</a>&nbsp;

The report added that Johnson will bring up the incident when he testifies this week before an inquiry into the British government's response to the coronavirus pandemic.&nbsp;

The sources told Daily Mail that the EU had "basically sequestered" and "impounded" five million doses of the vaccine.&nbsp;

One of the sources was quoted as saying, "Of course, the PM was enraged – they were putting British lives at risk to make a political point and distract from their own failings".&nbsp;

"He ordered officials to look at all options for responding, and that did include asking the security services to look at whether there were any options for physically going and taking the vaccines from the Netherlands and bringing them here," the source added.&nbsp;

Also read:&nbsp;<a href="https://www.wionews.com/world/uk-signs-new-treaty-with-rwanda-to-send-illegal-migrants-to-african-country-666573">UK signs new treaty with Rwanda to send illegal migrants to the African nation</a>&nbsp;

As quoted, a second source said of the raid: "Boris was infuriated, as you would expect, and he wanted to look at every avenue for responding. It went well beyond trade retaliation; it was diplomatic, security, and everything. He felt he was fighting for British lives and at one point he did ask whether there were military options for just going and getting these vaccines.&nbsp;

"Obviously, that would have had major repercussions, not least in terms of other vaccine supplies that were being manufactured in the EU. I don't know how far the idea got," the source added.&nbsp;

Watch:&nbsp;White house warns Putin could win if Ukraine aid dries up

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/white-house-warns-putin-could-win-if-ukraine-aid-dries-up-666590/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<h2>Did the Netherlands warn to block shipments?&nbsp;</h2>

Dutch government officials told Politico.eu in March 2021 that the Netherlands was prepared to halt shipments of AstraZeneca's Covid jabs if Britain did not agree to share vaccines more fairly with the EU.&nbsp;

(With inputs from agencies)&nbsp;

Former British prime minister Boris Johnson reportedly asked the security services to chalk out plans to raid the Dutch Covid vaccine factory in Leiden. UK-based Daily Mail newspaper reported citing diplomatic sources that Johnson made the call after saying the EU "stole" millions of AstraZeneca doses destined for Britain during the coronavirus (COVID-19) pandemic.

Former British prime minister Boris Johnson reportedly asked the security services to chalk out plans to raid the Dutch Covid vaccine factory in Leiden. UK-based Daily Mail newspaper reported citing diplomatic sources that Johnson made the call after saying the EU "stole" millions of AstraZeneca doses destined for Britain during the coronavirus (COVID-19) pandemic. Notably, the AstraZeneca vaccine was produced at two locations in the EU – the Netherlands and Belgium. The report added that the idea was dropped as the diplomats apparently warned that such an action would jeopardise the relations between both countries. Also read: 29-year-old stabbed in village of Aberfan, manhunt underway The report added that Johnson will bring up the incident when he testifies this week before an inquiry into the British government's response to the coronavirus pandemic. The sources told Daily Mail that the EU had "basically sequestered" and "impounded" five million doses of the vaccine. One of the sources was quoted as saying, "Of course, the PM was enraged – they were putting British lives at risk to make a political point and distract from their own failings". "He ordered officials to look at all options for responding, and that did include asking the security services to look at whether there were any options for physically going and taking the vaccines from the Netherlands and bringing them here," the source added. Also read: UK signs new treaty with Rwanda to send illegal migrants to the African nation As quoted, a second source said of the raid: "Boris was infuriated, as you would expect, and he wanted to look at every avenue for responding. It went well beyond trade retaliation; it was diplomatic, security, and everything. He felt he was fighting for British lives and at one point he did ask whether there were military options for just going and getting these vaccines. "Obviously, that would have had major repercussions, not least in terms of other vaccine supplies that were being manufactured in the EU. I don't know how far the idea got," the source added. Watch: White house warns Putin could win if Ukraine aid dries up × Did the Netherlands warn to block shipments? Dutch government officials told Politico.eu in March 2021 that the Netherlands was prepared to halt shipments of AstraZeneca's Covid jabs if Britain did not agree to share vaccines more fairly with the EU. (With inputs from agencies)

Did Boris Johnson really ask to plan raid on Dutch Covid vaccine factory?

covid-19-0

Covid 19, News on Covid 19, stories on Covid 19, articles on Covid 19, Covid 19 stories at Wion, Covid 19 news, Covid 19 latest news

covid 19-0